March 17 () - Pfizer said on Tuesday its experimental combination reduced the risk of disease progression or death by 40% in ...
We have harnessed rational strain engineering to pave the way for cost-effective manufacturing that can meet growing global ...
The finding suggests other chemo drugs, too, may be making cancer cells cause a surprising immune-system reaction.
University of Sheffield researchers are pioneering 'smart' drug delivery systems, combining Cold Atmospheric Plasma with ...
CLEVELAND, Ohio — A shift toward personalized treatment for breast cancer, ways to help patients live longer without their ...
A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...
Now, the person making the call is somebody somewhere who works for (the insurance company). It’s not my physician, who’s an ...
One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others ...
7hon MSN
Combination treatment benefits patients with advanced breast cancer that has spread to the brain
Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The ...
Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...
Scientists have mapped the genetics of cancer in cats for the first time at scale, uncovering major overlaps with human ...
Pfizer’s CDK4 inhibitor, atirmociclib, is already being investigated in a Phase III trial as a first-line therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results